Table 2 Interventions and outcomes of included studies
Study no. | Technique | Fusion level | Operation time (min) | Blood loss (ml) | The length of hospital stay (days) | Clinical effects | Complications | Fusion rate |
|---|---|---|---|---|---|---|---|---|
1 | ETD LIF PPSI | L1/2 L2/3 L3/4 L4/5 L5/S1 | 174 (117–251) | 57.6 (30–100) | 2.6 (1–12) | All patients improve on VAS and RMDQ | 8 patients RSE 2 patients RN 2 patients PSC 20% | 59.6% |
2 | PETLIF | L3/4 L4/5 L5/S1 | 60 ± 30 | None | 5 (2–21) | 43.9% patients improve on VAS and ODI | 8 patients RPP 13 patients AMC 36% | 77% |
3 | FE-MISTLIF | L3/4 L4/5 L5/S1 | 133.9 ± 16.1 one segment 241.3 ± 36.5 Two segments | 221.8 ± 98.5 (100–550) | 9.6 ± 1.3 (7–12) | All patients improve on VAS and ODI success rate 95.2% | 2 patients PNC | 92.9% |
4 | PTLIF | L2/3 L3/4 L4/5 L5/S1 | 120 ± 30 (group A or B) 240 ± 120 (group C) | None | 1.1 (0.8–2.8) | All patients improve on VAS and ODI | 3 patients TD 2 patients SIP | None |
5 | E-MISTLIF | None | 113.5 ± 6.3 (105–120) | 65 ± 38 (30–190) | 1.4 ± 1.3 | 90% patients improve on ODI, SF-36, EQ-5D | No complications | None |
6 | PTLIF | L2/3 L4/5 L5/S1 | 77 (62–100) | None | 1.0 (0.5–2.1) | All patients improve on VAS and ODI | 1 patient PNC 1 patient nonunion 1 patient revision | 88.9% |
7 | UBE | L3/4 L4/5 L5/S1 | 165.8 ± 25.5 | 85.5 ± 19.41 | None | All patients improve on VAS and ODI | 2 patients DT 3 patients PEH | None |
8 | BE-TLIF | L3/4 L4/5 L5/S1 | 169 ± 10 | 74 ± 9 | None | All patients improve on VAS | 1 patient L5 Paralysis 1 patient DT | None |
9 | PELIF | L4/5 | 167.5 ± 30.9 (135–220) | 70.0 ± 24.5 (50–100) | 1.2 ± 0.6 | All patients improve on VAS, SF-36 and ODI | No complications | 100% |